- Capital Cube•9 months ago
Capitalcube gives Alseres Pharmaceuticals, Inc. a score of 25.Our analysis is based on comparing Alseres Pharmaceuticals, Inc. with the following peers – Threshold Pharmaceuticals, Inc., Cortex Pharmaceuticals, Inc., Navidea Biopharmaceuticals, Inc., IMRIS Inc., Eli Lilly and Company, International Isotopes Inc., Synthetic Biologics, Inc., Fonar Corporation, iCAD, Inc. and General Electric Company (THLD-US, CORX-US, NAVB-US, IMRSQ-US, […] (Read more...) The post Alseres Pharmaceuticals, Inc. – Value Analysis (US OTC:ALSE) : October 23, 2015 appeared first on CapitalCube.
We're sorry this is all we were able to find about this topic.
|Day's Range||0.00 - 0.00|
|Avg Vol (3m)||0|
As of 11:46 AM EDT. Market closed.